MedPath

The evaluation test of cognitive function by oral consumption of the food which contain plasmaloge

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000031250
Lead Sponsor
CPCC Company Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
75
Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who constantly use oral medicines, functional foods and/or supplements having a possibility of affecting test results. 2) Subjects who have previous and/or current medical history of serious disease such as cerebral infarction, cerebrovascular disease, psychosis, dementia and so on. 3) Subjects who are given continuous treatment by taking medicines. 4) Subjects who excessive alcohol intake. 5) Subjects who's MMSE-J scores are under 26 points. 6) Subjects who have already been done neuropsychological test at clinic. 7) Subjects who have extremely irregular dining habits, and subjects who have midnight work or irregular shift work. 8) Subjects who have previous medical history of drug and/or food allergy. 9) Subjects who are participating the other clinical tests. Subjects who participated within 4-weeks prior to the current study and/or who plan to participate the other clinical tests. 10) Subjects who donated over 200mL blood and/or blood components within the last one month to the current study. 11) Males who donated over 400mL blood and/or blood components within the last three month to the current study. 12) Females who donated over 400mL blood and/or blood components within the last four month to the current study. 13) Males who will be collected over 1200mL blood and/or blood components, when the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 14) Females who will be collected over 800mL blood and/or blood components when, the sampling amounts within the last twelve month are adding to the planned sampling amounts of this study. 15) Others who have been determined ineligible by principal investigator or sub-investigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath